HighTower Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

HighTower Advisors’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$948K	Sell	9,572 -74	-0.8%	-$6.67K	﹤0.01%	2270
2026 Q1	$836K	Buy	9,646 +566	+6%	+$49.5K	﹤0.01%	2313
2025 Q4	$770K	Sell	9,080 -198	-2%	-$15.8K	﹤0.01%	2307
2025 Q3	$673K	Sell	9,278 -4,788	-34%	-$330K	﹤0.01%	2381
2025 Q2	$922K	Buy	14,066 +689	+5%	+$44.8K	﹤0.01%	2065
2025 Q1	$944K	Sell	13,377 -276	-2%	-$19.2K	﹤0.01%	2005
2024 Q4	$897K	Buy	13,653 +261	+2%	+$18K	﹤0.01%	2043
2024 Q3	$945K	Sell	13,392 -512	-4%	-$35.7K	﹤0.01%	1958
2024 Q2	$922K	Buy	13,904 +8,210	+144%	+$538K	﹤0.01%	1901
2024 Q1	$386K	Sell	5,694 -144	-2%	-$9.52K	﹤0.01%	2477
2023 Q4	$361K	Buy	5,838 +15	+0.3%	+$882	﹤0.01%	2574
2023 Q3	$343K	Buy	5,823 +1,557	+36%	+$95.5K	﹤0.01%	2489
2023 Q2	$255K	Buy	4,266 +843	+25%	+$50.1K	﹤0.01%	2677
2023 Q1	$202K	Sell	3,423 -372	-10%	-$22.4K	﹤0.01%	2749
2022 Q4	$235K	Buy	+3,795	New	+$228K	﹤0.01%	2653
2019 Q2	–	Sell	-4,827	Closed	-$248K	–	2445
2019 Q1	$248K	Buy	+4,827	New	+$240K	﹤0.01%	1830

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

HighTower Advisors's IHE Position: Q2 2026 in Review

HighTower Advisors reduced its iShares US Pharmaceuticals ETF (IHE) stake by 0.77% in Q2 2026, selling an estimated $6.67K and leaving 9,572 shares worth $948K. The position accounts for ﹤0.01% of the portfolio, ranked #2270.

HighTower Advisors first reported a position in IHE in Q1 2019 and has held it in 16 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

HighTower Advisors held 9,572 shares of iShares US Pharmaceuticals ETF worth $948K as of Q2 2026.
HighTower Advisors sold 74 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $6.67K.
iShares US Pharmaceuticals ETF made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2270 holding.
HighTower Advisors first reported a position in iShares US Pharmaceuticals ETF in Q1 2019 and has held it in 16 quarters since.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.